Skip navigation

Health economic papers


RA Moore, CJ Phillips, JM Pellissier, SX Kong. Health economic comparisons of rofecoxib versus conventional nonsteroidal antiinflammatory drugs for osteoarthritis in the United Kingdom. Journal of Medical Economics 2001 4: 1-17.

RA Moore, CJ Phillips. Cost of NSAID adverse effects to the NHS. Journal of Medical Economics 1999 2: 45-55.

CJ Phillips, A Burrell, RA Moore, GJ Bates, D Commins. Mucodyne: the economics of preventing surgery for grommets. Journal of Medical Economics 1999 2: 167-176.

M Tramèr, C Phillips, HJ McQuay, RA Moore. Nausea and vomiting after surgery: a cost-effectiveness analysis of treatment versus prophylaxis. Anaesthesia 1999 54: 226-235.

CJ Phillips, RA Moore. Developing a strategy for the prevention of hip fractures in the elderly due to osteoporosis: the application of economics to the findings from a clinical trial. International Journal of Clinical Practice 1998 l52: 335-340.

RA Moore, HJ McQuay, C. Phillips. Reflux oesophagitis: quantitative systematic review of the evidence of effectiveness of proton pump inhibitors and histamine antagonists. Bandolier Internet publications: http://www.jr2.ox.ac.uk:80/Bandolier/bandopubs/gordf/gord.html

C Phillips, A Moore. Trial and error - an expensive luxury: Economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. British Journal of Medical Economics 1997 11: 55-63.

C Phillips, A Moore. Implementing evidence-based medical interventions: the cost-effectiveness of Helicobacter pylori diagnosis and eradication. British Journal of Medical Economics 1996 10:47-57.